Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#3525 Prognostic factors for progression-free survival (PFS) in patients with metastatic bronchopulmonary neuroendocrine tumors (BP-NETs): Exploratory data from the phase 3 SPINET study

Introduction: SPINET (NCT02683941) evaluated lanreotide autogel/depot (LAN) in metastatic somatostatin receptor (SSTR)-positive typical and atypical (TC and AC) BP NETs.

Conference:

Presenting Author: Baudin E

Authors: Baudin E, Hörsch D, Singh S, Caplin M, Ferone D,

Keywords: bronchopulmonary neuroendocrine tumor, lanreotide autogel/depot, prognostic factor, spinet, typical/atypical carcinoid,

#3518 Effect of lanreotide autogel/depot (LAN) on tumor growth rate (TGR) in patients with metastatic bronchopulmonary neuroendocrine tumors (BP-NETs): Exploratory data from the phase 3 SPINET study

Introduction: SPINET (NCT02683941) evaluated LAN in metastatic somatostatin receptor (SSTR)-positive typical and atypical carcinoid (TC and AC) BP-NETs.

Conference:

Presenting Author: Capdevila J

Authors: Baudin E, Hörsch D, Singh S, Caplin M, Ferone D,

Keywords: bronchopulmonary neuroendocrine tumor, lanreotide autogel/depot, spinet, tumor growth rate, typical/atypical carcinoid,

#3186 Bronchopulmonary neuroendocrine tumors (bpNET) - A comparison of three subgroups

Introduction: bpNET are a rare malignancy of the lung, that arise sporadically (sp-bpNET), in the context of Multiple Endocrine Neoplasia Type 1 (MEN1) syndrome, or in the context of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH). Until now, bpNET of any type are regarded as similar entities. Clinically however, bpNET within MEN1 or DIPNECH rarely metastasize or lead to bpNET related death.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Levy S

Authors: Levy S, van den Broek M, Dijke K, Hartemink K, van Leeuwaarde R,

Keywords: bpNET, MEN1, DIPNECH,

#2763 Incidence and Outcome of Brain Metastasis in Patients Diagnosed with Neuroendocrine Neoplasm

Introduction: Brain metastases are rarely reported in patients with neuroendocrine carcinoma of non-lung origin and neuroendocrine tumors (NETs) of the gastroenteropancreatic or bronchopulmonary system.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Fatima A

Authors: Fatima A, Zaidi S,

Keywords: brain metastasis, grade 3 tumors,

#2220 Validation of a Blood-Based Biomarker Test for the Diagnosis and Management of Bronchopulmonary Neuroendocrine Tumors

Introduction: There is currently no effective blood biomarker for lung neuroendocrine neoplasia diagnosis and management.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Modlin I

Authors: Modlin I, Kidd M, Lewczuk-Myślińska A, Chung K, Ćwikła J,

Keywords: bronchopulmonary, lung, biomarker, PCR, diagnostics, progression,